Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
14,143.84
10,215.44
6,857.69
5,298.51
5,145.92
4,319.27
1,187.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
14,143.84
10,215.44
6,857.69
5,298.51
5,145.92
4,319.27
1,187.81
Raw Material Cost
1,904.44
1,637.41
1,255.57
1,082.63
609.04
435.72
183.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
3,455.60
2,946.27
2,842.76
2,881.83
2,694.76
1,394.22
805.67
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
86.33
73.34
108.98
118.26
75.28
76.80
67.46
Selling and Distribution Expenses
7,201.12
5,513.21
4,255.32
3,984.31
4,129.24
1,997.63
1,641.39
Other Expenses
-69.59
-11.27
-49.03
33.88
2.91
60.94
55.27
Total Expenditure (Excl Depreciation)
11,951.58
10,057.50
7,972.33
8,405.82
7,537.39
4,513.82
3,251.10
Operating Profit (PBDIT) excl Other Income
2192.2999999999997
157.89999999999998
-1114.6
-3107.3
-2391.5
-194.5
-2063.3
Other Income
-1,091.72
-280.10
-64.48
679.55
-869.75
-728.39
177.49
Operating Profit (PBDIT)
1,752.67
332.96
-753.58
-2,056.30
-3,014.45
-826.71
-1,787.87
Interest
86.33
73.34
108.98
118.26
75.28
76.80
67.46
Exceptional Items
0.60
154.73
23.53
22.02
152.67
34.81
2.98
Gross Profit (PBDT)
12,239.39
8,578.03
5,602.12
4,215.89
4,536.89
3,883.55
1,003.94
Depreciation
652.14
455.12
425.54
371.45
246.76
96.22
97.93
Profit Before Tax
1,014.80
-40.78
-1,264.57
-2,523.99
-3,183.83
-964.93
-1,950.28
Tax
27.50
17.36
-128.73
10.23
104.90
156.99
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
882.33
-102.60
-1,135.84
-2,534.23
-3,288.73
-1,121.92
-1,950.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
882.33
-102.60
-1,135.84
-2,534.23
-3,288.73
-1,121.92
-1,950.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
882.33
-102.60
-1,135.84
-2,534.23
-3,288.73
-1,121.92
-1,950.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
21,559.26
13,960.05
13,792.93
12,046.94
12,636.82
10,409.65
5,320.19
Earnings per share (EPS)
0.51
-0.06
-0.73
-1.7
-2.26
-0.83
-1.66
Diluted Earnings per share
0.51
-0.06
-0.73
-1.7
-2.26
-0.83
-1.66
Operating Profit Margin (Excl OI)
15.5%
1.55%
-16.25%
-58.64%
-46.47%
-4.5%
-173.71%
Gross Profit Margin
11.79%
4.06%
-12.23%
-40.63%
-57.08%
-20.11%
-155.95%
PAT Margin
6.24%
-1.0%
-16.56%
-47.83%
-63.91%
-25.97%
-164.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 38.46% vs 48.96% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 959.94% vs 90.97% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 363.94% vs 188.97% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 17.74% vs -32.75% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Innovent Biologics, Inc. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
14,143.84
16,298.57
-2,154.73
-13.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
14,143.84
16,298.57
-2,154.73
-13.22%
Raw Material Cost
1,904.44
1,624.47
279.97
17.23%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
3,455.60
3,650.49
-194.89
-5.34%
Power Cost
0
0
0.00
Manufacturing Expenses
86.33
3.43
82.90
2,416.91%
Selling and Distribution Expenses
7,201.12
5,134.87
2,066.25
40.24%
Other Expenses
-69.59
-1.21
-68.38
-5,651.24%
Total Expenditure (Excl Depreciation)
11,951.58
10,401.15
1,550.43
14.91%
Operating Profit (PBDIT) excl Other Income
2,192.25
5,897.42
-3,705.17
-62.83%
Other Income
-1,091.72
1,246.85
-2,338.57
-187.56%
Operating Profit (PBDIT)
1,752.67
7,547.32
-5,794.65
-76.78%
Interest
86.33
3.43
82.90
2,416.91%
Exceptional Items
0.60
-13.40
14.00
104.48%
Gross Profit (PBDT)
12,239.39
14,674.10
-2,434.71
-16.59%
Depreciation
652.14
426.24
225.90
53.00%
Profit Before Tax
1,014.80
7,104.26
-6,089.46
-85.72%
Tax
27.50
1,079.23
-1,051.73
-97.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
882.33
6,025.03
-5,142.70
-85.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
882.33
6,025.03
-5,142.70
-85.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
882.33
6,025.03
-5,142.70
-85.36%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
21,559.26
39,389.42
-17,830.16
-45.27%
Earnings per share (EPS)
0.51
1.01
-0.50
-49.50%
Diluted Earnings per share
0.51
1.01
-0.50
-49.50%
Operating Profit Margin (Excl OI)
15.50%
36.04%
0.00
-20.54%
Gross Profit Margin
11.79%
46.20%
0.00
-34.41%
PAT Margin
6.24%
36.97%
0.00
-30.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,414.38 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 38.46% vs 48.96% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 88.23 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 959.94% vs 90.97% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 284.44 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 363.94% vs 188.97% in Dec 2024
Annual - Interest
Interest 8.63 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 17.74% vs -32.75% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.50%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
